|International Myeloma Working Group molecular classification of multiple myeloma: spotlight review|
R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ...
Leukemia 23 (12), 2210-2221, 2009
|Genetics and cytogenetics of multiple myeloma: a workshop report|
R Fonseca, B Barlogie, R Bataille, C Bastard, PL Bergsagel, M Chesi, ...
Cancer research 64 (4), 1546-1558, 2004
|Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study|
SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...
Leukemia 26 (1), 149-157, 2012
|In multiple myeloma, t (4; 14)(p16; q32) is an adverse prognostic factor irrespective of FGFR3 expression|
JJ Keats, T Reiman, CA Maxwell, BJ Taylor, LM Larratt, MJ Mant, ...
Blood 101 (4), 1520-1529, 2003
|In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma|
DEL de Menezes, LM Pilarski, TM Allen
Cancer research 58 (15), 3320-3330, 1998
|The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer|
LH Regimbald, LM Pilarski, BM Longenecker, MA Reddish, ...
Cancer research 56 (18), 4244-4249, 1996
|International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment|
MA Dimopoulos, E Kastritis, E Terpos, P Sonneveld, N Leung, ...
Journal of Clinical Oncology 34 (13), 1544-1557, 2016
|Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.|
HM Serra, JF Krowka, JA Ledbetter, LM Pilarski
The Journal of Immunology 140 (5), 1435-1441, 1988
|Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia|
D Capello, U Vitolo, L Pasqualucci, S Quattrone, G Migliaretti, L Fassone, ...
Blood, The Journal of the American Society of Hematology 95 (2), 651-659, 2000
|In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears …|
PL Bergsagel, AM Smith, A Szczepek, MJ Mant, AR Belch, LM Pilarski
|RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability|
CA Maxwell, JJ Keats, M Crainie, X Sun, T Yen, E Shibuya, M Hendzel, ...
Molecular biology of the cell 14 (6), 2262-2276, 2003
|Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer|
S Adamia, CA Maxwell, LM Pilarski
Current Drug Targets-Cardiovascular & Hematological Disorders 5 (1), 3-14, 2005
|Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group|
J Laubach, L Garderet, A Mahindra, G Gahrton, J Caers, O Sezer, ...
Leukemia 30 (5), 1005-1017, 2016
|A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single …|
AJ Szczepek, K Seeberger, J Wizniak, MJ Mant, AR Belch, LM Pilarski
Blood, The Journal of the American Society of Hematology 92 (8), 2844-2855, 1998
|A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells|
EG Cen, C Dalton, Y Li, S Adamia, LM Pilarski, KVIS Kaler
Journal of microbiological methods 58 (3), 387-401, 2004
|A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.|
The Journal of experimental medicine 145 (3), 709-725, 1977
|Overexpression of transcripts originating from the MMSET locus characterizes all t (4; 14)(p16; q32)-positive multiple myeloma patients|
JJ Keats, CA Maxwell, BJ Taylor, MJ Hendzel, M Chesi, PL Bergsagel, ...
Blood 105 (10), 4060-4069, 2005
|CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications|
SP Treon, LM Pilarski, AR Belch, A Kelliher, FI Preffer, Y Shima, ...
Journal of immunotherapy 25 (1), 72-81, 2002
|Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice|
LM Pilarski, G Hipperson, K Seeberger, E Pruski, RW Coupland, ...
Blood, The Journal of the American Society of Hematology 95 (3), 1056-1065, 2000
|Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone|
SP Treon, JA Mollick, M Urashima, G Teoh, D Chauhan, A Ogata, N Raje, ...
Blood, The Journal of the American Society of Hematology 93 (4), 1287-1298, 1999